Courtesy of Amgen
Company Information
As of 2/1/2023
Country
U.S.
Headquarters
Thousand Oaks, Calif.
Industry
Pharmaceuticals
CEO
Robert A. Bradway
Website
Company Type
Public
Ticker
AMGN
Revenues ($M)
$26,330
Profits ($M)
$6,835
Market Value ($M)
$140,459
Employees
24,200
Figures are for the latest twelve months ended Sept. 30, 2022. Market value as of Jan. 20, 2023. Sources: Bloomberg; S&P Global.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$25,979
2.2%
Profits ($M)
$5,893
-18.9%
Assets ($M)
$61,165
-
Total Stockholder Equity ($M)
$6,700
-
Profit Ratios
Profit as % of Revenues
22.7%
Profits as % of Assets
9.6%
Profits as % of Stockholder Equity
88%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
1,028
EPS % Change (from 2020)
-16.5%
EPS % Change (5 year annual rate)
0.1%
EPS % Change (10 year annual rate)
9.8%
Total Return
Total Return to Investors (2021)
1%
Total Return to Investors (5 year, annualized)
12.2%
Total Return to Investors (10 year, annualized)
16.2%
Amgen Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2021 | $25,4248.8% | $7,264-7.4% | $62,948 | $9,409 |
| 2020 | $23,362-1.6% | $7,842-6.6% | $59,707 | $9,673 |
| 2019 | $23,7473.9% | $8,394324.2% | $66,416 | $12,500 |
| 2018 | $22,849-0.6% | $1,979-74.4% | $79,954 | $25,241 |
| 2017 | $22,9916.1% | $7,72211.3% | $77,626 | $29,875 |
SHOW MORE
Lists ranking Amgen
Latest news for Amgen
- Newsletters
Inclusion in the Dow does not guarantee a bump to your share priceAugust 27, 2020, 10:25 AM UTC - Newsletters
Can the Dow’s Big Tech makeover finally push the blue chip index above 30,000?August 25, 2020, 9:47 AM UTC - Finance
Salesforce, Amgen, and Honeywell Int’l will join Dow Jones Industrial AverageAugust 24, 2020, 9:45 PM UTC
